The percentage of patients achieving complete remission of urticaria increases with repeated courses of treatment

J Allergy Clin Immunol Pract. 2019 Jan;7(1):339-340. doi: 10.1016/j.jaip.2018.06.011. Epub 2018 Jul 2.

Authors

Andrea Matucci¹, Francesca Nencini², Oliviero Rossi¹, Sara Pratesi², Paola Parronchi², Enrico Maggi², Alessandra Vultaggio³

Affiliations

¹ Immunoallergology Unit, Careggi University Hospital, Florence, Italy.
² Center DENOTHE and Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
³ Immunoallergology Unit, Careggi University Hospital, Florence, Italy. Electronic address: vultaggioalessandra@gmail.com.

PMID: 30599882
DOI: 10.1016/j.jaip.2018.06.011

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Angioedema
Chronic Urticaria / drug therapy*
Clinical Protocols
Female
Follow-Up Studies
Humans
Immunoglobulin E / immunology
Immunoglobulin E / metabolism
Male
Middle Aged
Omalizumab / therapeutic use*
Remission Induction
Severity of Illness Index
Young Adult

Substances

Omalizumab
Immunoglobulin E